Angioimmunoblastic T-cell lymphoma screening: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Angioimmunoblastic T-cell lymphoma}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing...")
 
(Category)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angioimmunoblastic T-cell lymphoma}}
{{Angioimmunoblastic T-cell lymphoma}}
 
{{CMG}}; {{AE}} {{AS}}
Please help WikiDoc by adding more content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
 
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.
==Screening==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.<ref> Recommendations. U.S Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=angioimmunoblastic+T-cell+lymphoma Accessed on November 27, 2015</ref>
==References==
==References==
{{reflist|2}}
{{Reflist|2}}
 
{{WH}}
{{WS}}
[[Category:Disease]]
[[Category:Pathology]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Disease]]
[[Category:Medicine]]
[[Category:Needs content]]
[[Category:Hematology]]
 
[[Category:Immunology]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 03:22, 24 October 2017

Angioimmunoblastic T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Biopsy

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angioimmunoblastic T-cell lymphoma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angioimmunoblastic T-cell lymphoma screening

CDC on Angioimmunoblastic T-cell lymphoma screening

Angioimmunoblastic T-cell lymphoma screening in the news

Blogs on Angioimmunoblastic T-cell lymphoma screening

Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma

Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.[1]

References

  1. Recommendations. U.S Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=angioimmunoblastic+T-cell+lymphoma Accessed on November 27, 2015

Template:WH Template:WS